• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC CRYOCATH LP FLEXCATH STEERABLE SHEATH; CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC CRYOCATH LP FLEXCATH STEERABLE SHEATH; CATHETER, STEERABLE Back to Search Results
Model Number 4FC12
Device Problem Insufficient Information (3190)
Patient Problem Pseudoaneurysm (2605)
Event Date 01/01/2016
Event Type  Injury  
Manufacturer Narrative
Medtronic cryocath was made aware of this event through a search of literature publications.It was not possible to ascertain specific device information from the literature publication or to match the event with previously reported events.This information is based entirely on journal literature.This event occurred outside the us.All information provided is included in this report.Patient information is limited due to confidentiality concerns.Multiple patients were referenced in the article.The baseline characteristics of the patients referenced in the article is gender/age is male/(b)(6) years old.Without a lot number or device serial number, the manufacturing date cannot be determined.Since no device id was provided, it is unknown if this event has been previously reported.Referenced article: evaluation of the achieve mapping catheter in cryoablation for atrial fibrillation: a prospective randomized trial.J.Intervent.Card.Electrophysiol.2016;45(2):179-187.(b)(4).
 
Event Description
Gang y, gonna h, domenichini g, et al.Evaluation of the achieve mapping catheter in cryoablation for atrial fibrillation: a prospective randomized trial.J.Intervent.Card.Electrophysiol.2016;45(2):179-187.Purpose: the purpose of this study is to establish the role of achieve mapping catheter in cryoablation for paroxysmal atrial fibrillation (paf) in a randomized trial.Methods: a total of 102 patients undergoing their first ablation for paf were randomized at 2:1 to an achieve- or lasso-guided procedure.Study patients were systematically followed up for 12 months with holter monitoring.Primary study endpoint was acute procedure success.Secondary endpoint was clinical outcomes assessed by af free at 6 and 12 months after the procedure.Results: of 102 participants, 99 % of acute procedure success was achieved.Significantly shorter procedure duration with the achieve guided group than with the lasso-guided group (118 ± 18 vs.129 ± 21 min, p <(><<)> 0.05) was observed as was the duration of fluoroscopy (17 ± 5 vs.20 ± 7 min, p <(><<)> 0.05) by subgroup analysis focused on procedures performed by experienced operators.In the whole study patients, procedure and fluoroscopic durations were similar in the achieve- (n = 68) and lasso-guided groups (n = 34).Transient phrenic nerve weakening was equally prevalent with the achieve and lasso.No association was found between clinical outcomes and the mapping catheter used.The use of second generation cryoballoon (n = 68) reduced procedure time significantly compared to the first-generation balloon (n = 34); more patients were free of af in the former than the latter group during follow-up.Conclusions: the use of the achieve mapping catheter can reduce procedure and fluoroscopic durations compared with lasso catheters in cryoablation for paf after operators gained sufficient experience.The type of mapping catheter used does not affect procedure efficiency and safety by models of cryoballoon.The literature publication reported the following patient complications: there were two (2) patients who experienced pseudo-aneurysms; which required a thrombin injections.No further patient complications have been reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLEXCATH STEERABLE SHEATH
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
MEDTRONIC CRYOCATH LP
16771 chemin ste-marie
kirkland H9H 5 H3
CA  H9H 5H3
Manufacturer (Section G)
MEDTRONIC CARDIAC RHYTHM HEART FAILURE
8200 coral sea st ne
mounds view MN 55112
Manufacturer Contact
anne schilling
8200 coral sea st ne
mounds view, MN 55112
7635052036
MDR Report Key5511827
MDR Text Key40775616
Report Number3002648230-2016-00097
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K081049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 03/08/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/18/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model Number4FC12
Device Catalogue Number4FC12
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/08/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00062 YR
-
-